- Home
- OSUR vs REFI Comparison
OSUR vs REFI Comparison
Compare OSUR & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- REFI
- Stock Information
- Founded
- OSUR 2000
- REFI 2021
- Country
- OSUR United States
- REFI United States
- Employees
- OSUR N/A
- REFI N/A
- Industry
- OSUR Medical/Dental Instruments
- REFI Real Estate Investment Trusts
- Sector
- OSUR Health Care
- REFI Real Estate
- Exchange
- OSUR Nasdaq
- REFI Nasdaq
- Market Cap
- OSUR 289.4M
- REFI 306.1M
- IPO Year
- OSUR 1986
- REFI 2021
- Fundamental
- Price
- OSUR $3.62
- REFI $16.16
- Analyst Decision
- OSUR Hold
- REFI Strong Buy
- Analyst Count
- OSUR 2
- REFI 3
- Target Price
- OSUR $5.50
- REFI $20.00
- AVG Volume (30 Days)
- OSUR 1.0M
- REFI 118.5K
- Earning Date
- OSUR 11-06-2024
- REFI 11-07-2024
- Dividend Yield
- OSUR N/A
- REFI 11.63%
- EPS Growth
- OSUR N/A
- REFI N/A
- EPS
- OSUR 0.15
- REFI 2.00
- Revenue
- OSUR $224,263,000.00
- REFI $56,860,278.00
- Revenue This Year
- OSUR N/A
- REFI N/A
- Revenue Next Year
- OSUR N/A
- REFI $4.27
- P/E Ratio
- OSUR $24.43
- REFI $8.08
- Revenue Growth
- OSUR N/A
- REFI 6.49
- 52 Week Low
- OSUR $3.58
- REFI $14.82
- 52 Week High
- OSUR $8.45
- REFI $17.65
- Technical
- Relative Strength Index (RSI)
- OSUR 37.25
- REFI 56.28
- Support Level
- OSUR $3.76
- REFI $15.69
- Resistance Level
- OSUR $3.70
- REFI $16.24
- Average True Range (ATR)
- OSUR 0.17
- REFI 0.20
- MACD
- OSUR -0.03
- REFI -0.02
- Stochastic Oscillator
- OSUR 0.83
- REFI 79.03
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.